GSTP1 and breast carcinoma: Our results further demonstrated that the GSTP1 105Val genotype provided a good prognosis for breast cancer patients in a Chinese population after receiving CTX-based chemotherapy (HR = 0.77, 95% CI: 0.45-0.91).